United Therapeutics Corp
NASDAQ:UTHR

Watchlist Manager
United Therapeutics Corp Logo
United Therapeutics Corp
NASDAQ:UTHR
Watchlist
Price: 361.97 USD 0.66%
Market Cap: 16.2B USD
Have any thoughts about
United Therapeutics Corp?
Write Note

Revenue Breakdown

Breakdown by Geography
United Therapeutics Corp

Total Revenue: 2.3B USD
100%
United States: 2.2B USD
94.6%
Rest-Of-World: 125.3m USD
5.4%

Breakdown by Segments
United Therapeutics Corp

Total Revenue: 2.3B USD
100%
Total Tyvaso: 1.2B USD
53%
Tyvaso Dpi: 731.1m USD
31.4%
Nebulized Tyvaso: 502.6m USD
21.6%
Remodulin: 494.8m USD
21.3%
Orenitram: 359.4m USD
15.4%
Unituxin: 198.9m USD
8.5%
Adcirca: 28.9m USD
1.2%
Other: 11.8m USD
0.5%
Show More
Show Less

See Also

Discover More